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Cell transfer restores sperm production in infertile mice
By Stephen Bradt

Scientists at the School have successfully
transplanted specialized cells that are critical to
sperm development in mice, restoring sperm
production in once-infertile animals.
The research may give scientists a better
understanding of how Sertoli cells—which surround spermatogenic stem cells—nourish
sperm production and the survival of stem
cells.
“Spermatogenesis is a highly organized
process, requiring just the right environment,
or ‘niche,’ around the germ line stem cells,” said
Ralph L. Brinster, V’60, professor of reproductive physiology at the School. “The Sertoli cells
are essential to this environment, and it
appears that by replacing them, we can essentially reconstruct the niche in which sperm
development takes place.”
Much of the volume of a mammalian testis
consists of tightly coiled seminiferous tubules
that hold mature sperm. Sperm development
also occurs within these tubules, which are
home to spermatogenic stem cells, the seeds
from which spermatogenesis arises. Seminiferous tubules are lined with Sertoli cells, which
are thought to nurture sperm cells as they
develop and facilitate their eventual passage
out of the testis.
Brinster and colleagues worked with Steel
mutant mice, which are congenitally infertile
due to a Sertoli cell defect. Before inserting
healthy Sertoli cells, the researchers treated the
mice's testes with busulfan and cadmium to
remove any defective germ cells and Sertoli
cells. The seminiferous tubules remained, likely
providing the structural support needed to
completely reconstitute spermatogenesis from
donor cells.
The Brinster group’s technique for transplanting Sertoli cells will likely allow scientists
to study stem cells’ specialized environment in
a way that has not been possible before. Currently, the best-studied stem cells are those that
generate blood cells, even though these cells,
which reside in bone marrow, are relatively
inaccessible to researchers.
“I believe Dr. Brinster’s new results have
catapulted the spermatogenic stem cell system
into a position of maximum experimental flexibility among all other stem cell systems in the
body,” said John R. McCarrey, professor of cell
and molecular biology at the University of
Texas at San Antonio, who was not involved in

this work. “This may lead to significant new
insight into the manner in which the spermatogenic stem cell works in particular as well
as to additional information about how all
stem cells work in general.”
Brinster’s work could eventually prove useful in the treatment of certain types of infertility in men, although complete spermatogenesis
was established in only 1.5 to 3 percent of seminiferous tubules in this experiment.
“Male infertility can be caused either by
defective germ cells or by a testicular environment that fails to promote proper spermatogenesis,” Brinster said. “While several assisted
reproductive technologies, such as in vitro fertilization or intracytoplasmic sperm injection,
are now available for patients with low sperm
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counts, infertile patients with Sertoli cell
defects have limited options.”
The technique developed by Brinster and
his colleagues may provide a new way of
replacing defective Sertoli cells with healthy
ones, which may initiate normal spermatogenesis in some infertile patients.
Brinster was joined in the research by
Takashi Shinohara, now at Kyoto University,
and Kyle E. Orwig and Mary R. Avarbock in
Penn’s School of Veterinary Medicine. The
work was funded by the Japan Society for Promotion of Science, the National Institute of
Child Health and Human Development, the
Commonwealth and General Assembly of
Pennsylvania and the Robert J. Kleberg Jr. and
Helen C. Kleberg Foundation.
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Dear PennHIP Members, Veterinarians, Pet Owners, and Dog Breeders:
I am pleased to announce that the University of Pennsylvania has once again
become the home of PennHIP. Synbiotics and the University of Pennsylvania
have reached an agreement that transferred the PennHIP license back to Penn
on November 15, 2002. We at PennHIP would like to recognize Synbiotics
(and before that, ICG) for the years of good management, helping to grow
PennHIP to the size it is today. We are hopeful that this friendly departure will
strengthen both entities. Like the OFA, PennHIP will now be a “not-for-profit”
organization and we look forward to working with the American Kennel Club
and other breed clubs.
We anticipate some confusion in the transition and we thank you in advance
for your understanding and tolerance through this period. Penn’s acquisition of
PennHIP is an exceptional opportunity to put PennHIP on equal footing with
other not-for-profit screening methods. The expanding body of published scientific articles provides comparative evidence that PennHIP is the superior
screening method for hip dysplasia. We are excited about this new development and we look forward to widespread utilization of PennHIP to improve
the hip quality of all dog breeds afflicted with hip dysplasia.
Visit our web site for periodic updates.
Thank you,
Gail K. Smith, V.M.D., Ph.D.
Director, PennHIP
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